The observed association of GCNT1 expression with CLL prognosis is incongruent with data reported for solid tumors (e.g., bladder and prostate cancers), in which high expression of GCNT1 was associated with poor prognosis, presumably through the protection of tumors from NK cells (56–58). The gene discussed is GCNT1; the disease is B-cell chronic lymphocytic leukemia.